Does INSULIN GLARGINE Cause Off label use? 6,842 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6,842 reports of Off label use have been filed in association with INSULIN GLARGINE (Lantus Solostar). This represents 6.9% of all adverse event reports for INSULIN GLARGINE.
6,842
Reports of Off label use with INSULIN GLARGINE
6.9%
of all INSULIN GLARGINE reports
21
Deaths
317
Hospitalizations
How Dangerous Is Off label use From INSULIN GLARGINE?
Of the 6,842 reports, 21 (0.3%) resulted in death, 317 (4.6%) required hospitalization, and 44 (0.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INSULIN GLARGINE. However, 6,842 reports have been filed with the FAERS database.
What Other Side Effects Does INSULIN GLARGINE Cause?
Blood glucose increased (19,234)
Inappropriate schedule of product administration (8,982)
Product storage error (7,743)
Visual impairment (5,793)
Blood glucose decreased (4,552)
Drug ineffective (4,351)
Hypoglycaemia (4,212)
Injection site pain (3,574)
Device issue (3,175)
Incorrect dose administered (3,070)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which INSULIN GLARGINE Alternatives Have Lower Off label use Risk?
INSULIN GLARGINE vs INSULIN GLARGINE-YFGN
INSULIN GLARGINE vs INSULIN GLARGINE\LIXISENATIDE
INSULIN GLARGINE vs INSULIN GLULISINE
INSULIN GLARGINE vs INSULIN HUMAN
INSULIN GLARGINE vs INSULIN LISPRO